HCA Healthcare will host its Investor Day beginning at 8:00 a.m. CT. A team of HCA Healthcare leaders will offer perspectives on the company’s financial performance, operations, and strategy to drive growth and create value. As part of investor day, the company will discuss its strategic assessment of market opportunities and capital capacity. Based on this assessment, and subject to certain underlying assumptions, it is currently targeting over the next five years: adjusted EBITDA growth between 4% and 6%; and diluted earnings per share growth between 8% and 12%. The company’s targeted annual growth ranges are a composite of anticipated results over time. Actual performance in any given year may vary from these ranges for a variety of reasons.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on HCA:
- HCA Healthcare downgraded to Buy from Conviction Buy at Goldman Sachs
- HCA Healthcare price target lowered to $280 from $310 at Deutsche Bank
- HCA Healthcare price target lowered to $254 from $267 at Wells Fargo
- HCA Healthcare price target lowered to $276 from $298 at Leerink
- HCA Healthcare price target lowered to $300 from $340 at Truist
